Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid, Radiation, and Bevacizumab in Pediatric High-Grade and Brainstem Gliomas
NCT00879437Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Sep 2009
- Primary completion
- Aug 2015
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid, bevacizumab in glioma, brainstem glioma, diffuse intrinsic pontine glioma (DIPG), glioblastoma (GBM), anaplastic astrocytoma (AA), sponsored by Baylor College of Medicine. Started Sep 2009; status: completed.
02
Drugs
valproic acidbevacizumab
03
Conditions
gliomabrainstem gliomadiffuse intrinsic pontine glioma (DIPG)glioblastoma (GBM)anaplastic astrocytoma (AA)
Beyond the preview
Go deeper on NCT00879437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00879437.